NanoSpot.ai, Opto to distribute SARS-CoV-2 antibody test in Greece

LabPulse.com staff writers
Sep 12, 2022
2022 04 22 17 54 4420 Business Handshake Man 400

NanoSpot.ai on Tuesday announced an agreement with Opto, a provider of connected diagnostic tests, for the distribution of NanoSpot.ai’s SARS-CoV-2 Total Antibody Test in Greece.

The partnership resulted from a joint clinical study in Athens that evaluated NanoSpot.ai's artificial intelligence (AI)-enabled, agglutination-based testing platform.

Its SARS-CoV-2 Total Antibody Test leverages the agglutination-based method and an AI-enabled mobile application to provide antibody test results at point-of-care.

The approach has demonstrated 98% sensitivity and 100% specificity, and provides results in less than three minutes, NanoSpot.ai said.

The firm received the CE Mark for the test in May.

Latest in Artificial Intelligence
Artificial Intelligence Ai Suit Social
EarlySign colon cancer algorithm to be offered in Roche Navify suite of digital medical algorithms
May 1, 2023
Lab Scientist Computer Ai Social
PathAI, ConcertAI collaborate on real-world data pathology solution
April 25, 2023
Visit our Molecular Diagnostics Community
Sponsored
Visit our Molecular Diagnostics Community
May 11, 2023
Artificial Intelligence Ai Abstract Social
ThinkCyte, Sysmex, Juntendo University partner on chronic myelogenous leukemia research
April 18, 2023
Related Stories
2021 11 12 17 39 5991 Coronavirus Covid Blue 400
Molecular Diagnostics
Quest Diagnostics sees decline in August COVID test demand
2022 09 09 16 29 7140 Computer Head 400
Immune System Diseases
Lunaphore, Nucleai to provide AI-based spatial biology analysis
2018 08 28 18 59 9066 Artificial Intelligence Ai 400
Artificial Intelligence
Using the human voice to detect COVID, COPD
Visit our Molecular Diagnostics Community
Sponsor Content
Visit our Molecular Diagnostics Community
More in Artificial Intelligence
EarlySign colon cancer algorithm to be offered in Roche Navify suite of digital medical algorithms
The addition of ColonFlag to the Navify suite is the latest development in an ongoing collaboration between EarlySign and Roche for early lung and gastric cancer detection.
May 1, 2023
Artificial Intelligence Ai Suit Social
PathAI, ConcertAI collaborate on real-world data pathology solution
A histopathology dataset comprising patient-level and population-level real-world data allows for greater insights into treatment dynamics and standards of care on both scales, the companies said.
April 25, 2023
Lab Scientist Computer Ai Social
Machine learning model more accurately predicts strokes
Machine learning and patient data upon hospital arrival helped develop a model that predicts strokes with greater accuracy than current models.
April 20, 2023
Brain Stroke Stroke Social
ThinkCyte, Sysmex, Juntendo University partner on chronic myelogenous leukemia research
The collaborative team has been developing approaches to characterize CML-specific morphological differences between blood cancer cells and normal white blood cells using Ghost Cytometry.
April 18, 2023
Artificial Intelligence Ai Abstract Social
Techcyte, Mayo Clinic to collaborate on algorithms for pathology platform
Techcyte’s Clinical Pathology AI Platform, which is CE-marked under IVDR and designated for research use only in the U.S., imports digital images of liquid-based samples from whole-slide scanners.
March 14, 2023
Artificial Intelligence Ai Abstract Social
Alverno Laboratories to expand Ibex’s AI-powered cancer diagnostics suite throughout its Midwest network
Alverno, among the first U.S. laboratory networks to digitize its pathology services, is also the first to offer the Ibex AI-supported cancer diagnostic service in the U.S.
March 9, 2023
Artificial Intelligence Ai Hand Social
Viz.ai platform to be used in patient enrollment for pulmonary embolism trial
Research institutions participating in the PE-TRACT trial will use the platform, Viz Recruit, to find, screen, and enroll trial candidates.
March 6, 2023
Artificial Intelligence Lung Color Social
Guardant NSCLC biomarker test to incorporate Lunit’s AI-based scoring algorithm
The integrated Lunit Scope PD-L1 algorithm will augment the TissueNext test’s detection of the PD-L1 biomarker in tissue samples using an AI-based scoring system.
February 1, 2023
Computer Ai Artificial Illustration Social
With Bill & Melinda Gates Foundation grant, VisualDx to develop diagnostic, surveillance tools for underserved
The firm said it will use the funds to expand equitable access to its clinical decision support, artificial intelligence, and machine learning tools.
January 18, 2023
Computer Brain Money Social
Paige joins forces with Microsoft on pathology AI
Digital pathology company Paige is partnering with Microsoft on AI technology to develop clinical applications and computational biomarkers for digital pathology images to transform cancer diagnosis and patient care.
January 12, 2023
Artificial Intelligence Ai Hand Social
Avenda Health gets FDA 510(k) clearance for iQuest prostate cancer platform
The iQuest platform provides physicians with a 3D visualization, enabling treatment decisions that consider the extent of the cancer rather than treating the whole organ.
December 8, 2022
Prostate Cancer 3 D Rendering Social
PathomIQ presents data on AI predictive model at SABCS
The model predicts the response to neoadjuvant chemotherapy in patients with triple-negative breast cancer through extracting morphological features.
December 8, 2022
Artificial Intelligence Ai Head Social
Page 1 of 14
Next Page